Durable Response to Pazopanib in a Patient with Fumarate Hydratase-Mutant Tubulocystic Renal Cell Carcinoma

Tubulocystic carcinoma of the kidney (TC-RCC) is a rare renal tumor and has been recently included as a distinct entity in WHO classification of renal neoplasms. We report the case of a patient with metastatic tubulocystic RCC whose disease progressed through standard of care treatment for nonclear...

Descripción completa

Detalles Bibliográficos
Autores principales: Othman, Anjum, Kumar, Shiyam, Qureshi, Asim, Jawa, Zabah M., Burney, Ikram A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105324/
https://www.ncbi.nlm.nih.gov/pubmed/37069897
http://dx.doi.org/10.1159/000528697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105324/
https://www.ncbi.nlm.nih.gov/pubmed/37069897
http://dx.doi.org/10.1159/000528697

Ejemplares similares